Trial Information

Summary: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Efficacy and Safety of TZP-101 when Administered as a 30 Minute I.V. Infusion to Subjects with Severe Gastroparesis due to Diabetes Mellitus (TZP-101-CL-G004)

Do You Have Type 1 or Type 2 Diabetes and have been diagnosed with Gastroparesis?

Massachusetts General Hospital is seeking volunteers to participate in a Clinical Research Study using an investigational medication.
To qualify you must be:
• 18-80 years of age
•Diagnosed with Type 1 or Type 2 Diabetes Mellitus
•Diagnosed with gastroparesis
•Male or Female must be willing to use contraceptives (birth control) to prevent pregnancy
•Able and willing to participate up to 35 days from screening through follow-up, including 5 consecutive overnight stays

Do you have any of the following conditions:
•vomiting of undigested food—sometimes several hours after a meal
•early feeling of fullness after only a few bites of food
•abdominal bloating
•nausea
•pain in the upper abdomen

Qualified participants will receive research study related:
•Lab Assessments
•EKG’s
•Investigational Medication
Monetary compensation is available for eligible subjects.

If you would like to learn more about participating in this study, please send an e-mail message using the form below.